MoonLake Immunotherapeutics reported cash from operations of -$55.56M and free cash flow of -$55.56M for the quarter ended Jun 2026, down 1.9% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||
| Net Income | -6.29M | -53.64M | -15.88M | -17.42M | -14.74M | -16.47M | -12.22M | -12.35M | -11.62M | -7.89M | -13.97M | -24.76M | -36.11M | -46.40M | -40.56M | -56.05M | -70.69M | -63.02M | -69.71M | -61.80M | ||
| Share-based CompensationStock Comp. | 1.86M | 9.05M | 1.99M | 2.48M | 2.59M | 2.60M | 2.58M | 1.50M | 1.43M | 1.61M | 1.68M | 1.83M | 1.84M | 1.93M | 2.29M | 3.31M | 3.71M | 3.59M | 13.36M | 2.55M | ||
| Cash from OperationsCash from Ops. | -2.02M | -35.18M | -14.19M | -20.76M | -9.35M | -11.60M | -9.02M | -12.16M | -9.25M | -12.34M | -14.95M | -27.89M | -25.28M | -48.47M | -38.14M | -54.53M | -44.54M | -58.79M | -66.29M | -55.56M | ||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.33M | 0.37M | 0.32M | 0.38M | 0.40M | 0.72M | 0.78M | 0.72M | 0.84M | 0.90M | ||||||||||||
| Change in Working Capital | ||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.21M | 1.57M | 2.25M | -3.03M | 0.27M | -0.80M | 3.57M | 0.53M | -0.96M | -1.57M | 1.65M | 1.66M | 5.57M | -1.72M | 3.01M | 5.07M | 8.20M | 4.27M | -6.17M | -6.34M | ||
| Change in Accured ExpensesChange Accured Exp. | 2.10M | 4.51M | -1.35M | -0.11M | 1.90M | 2.24M | -3.95M | -0.67M | 1.42M | 2.87M | -2.81M | 1.69M | 2.11M | 4.17M | -1.56M | -1.81M | 12.86M | -6.90M | 7.12M | 3.79M | ||
| Investing Activities | ||||||||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.05M | 0.02M | -2.00 | 1.00 | 0.28M | 0.21M | 0.13M | 0.18M | 1.70M | -0.00M | -1.11M | 0.75M | -0.00M | ||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 9.90M | 19.65M | 12.68M | 1.36M | 117.15M | 59.12M | -1.30M | 87.59M | -0.21M | 144.83M | 205.91M | 88.40M | 29.26M | 59.17M | 59.07M | |||||||
| Cash from Investing ActivitiesCash from Investing | -0.01M | -0.05M | -0.02M | 2.00 | -42.23M | 9.90M | 19.65M | 12.68M | -174.38M | 116.87M | -28.80M | -87.74M | 58.28M | -147.33M | 56.25M | 88.25M | 88.40M | -29.91M | 0.10M | 0.32M | ||
| Financing Activities | ||||||||||||||||||||||
| Other financing activitiesOther financing | 0.11M | 0.00M | -0.00M | 0.00M | 482.45M | 0.09M | 52.45M | 0.10M | 0.38M | 71.92M | 0.17M | 0.55M | ||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.50M | 43.26M | 15.00M | 104.69M | 0.00M | 451.29M | 28.42M | 50.98M | 0.18M | 0.15M | 73.12M | 0.48M | 72.39M | 30.64M | 234.62M | |||||||
| Change in Capital Stock | ||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 14.60M | 52.54M | 6.01M | 44.31M | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.00M | 0.00M | -0.01M | -0.05M | 0.07M | -0.01M | -535.00 | -0.14M | 0.01M | 0.06M | 0.05M | -0.02M | -0.33M | 0.42M | -0.09M | 1.39M | -0.28M | 0.09M | -0.48M | 0.03M | ||
| Change in Cash | -1.53M | 8.04M | 0.80M | 83.87M | -51.50M | -1.70M | 10.62M | 451.66M | -183.62M | 133.00M | 7.27M | -115.65M | 32.86M | -195.23M | 91.14M | 35.12M | 44.05M | -16.22M | -36.03M | 179.41M | ||
| Free Cash FlowFCF | -2.03M | -35.23M | -14.20M | -20.76M | -9.35M | -11.60M | -9.02M | -12.16M | -9.25M | -12.63M | -15.16M | -27.89M | -25.41M | -48.65M | -39.84M | -54.53M | -43.43M | -58.79M | -67.03M | -55.56M | ||
| Net Cash FlowNCF | -1.53M | 8.04M | 0.80M | 83.92M | -51.58M | -1.69M | 10.62M | 451.80M | -183.63M | 132.94M | 7.23M | -115.63M | 33.19M | -195.65M | 91.23M | 33.72M | 44.34M | -16.31M | -35.54M | 179.39M |